Hepatocellular Carcinoma Translational Precision Medicine Approaches /

This book provides a comprehensive overview of the current limitations and unmet needs in Hepatocellular Carcinoma (HCC) diagnosis, treatment, and prevention. It also provides newly emerging concepts, approaches, and technologies to address challenges. Topics covered include changing landscape of HC...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Hoshida, Yujin (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Cham : Springer International Publishing : Imprint: Humana, 2019.
Έκδοση:1st ed. 2019.
Σειρά:Molecular and Translational Medicine,
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Part 1: Clinical demographics and management
  • 1. Risk Factors of Hepatocellular Carcinoma for Precision Personalized Care
  • 2. Hepatocellular Carcinoma Surveillance and Staging
  • 3. Changing Epidemiology of Hepatocellular Carcinoma and Role of Surveillance
  • Part 2: Diagnosis and prognostication
  • 4. Radiological diagnosis and characterization of HCC
  • 5. Analysis of Hepatocellular Carcinoma Tissue for Biomarker and Therapeutic Target Discovery
  • 6. Molecular subtypes and genomic signatures of hepatocellular carcinoma for prognostication and therapeutic decision making
  • 7. Liquid Biopsy in Hepatocellular Carcinoma
  • Part 3: Treatment
  • 8. Surgical Therapies in Hepatocellular Carcinoma
  • 9. Interventional Radiologic Therapies for Hepatocellular Carcinoma: From Where We Began To Where We Are Going
  • 10. Precision Locoregional Therapies for Hepatocellular Carcinoma: Percutaneous Ablation and Radiotherapy
  • 11. Molecular-targeted therapies in hepatocellular carcinoma
  • 12. Immune therapies
  • 13. Prevention Strategies for Hepatocellular Carcinoma
  • Part 4: Molecular pathogenesis and therapeutic discovery
  • 14. Molecular Alterations and Heterogeneity in Hepatocellular Carcinoma
  • 15. Stromal and Immune Drivers of Hepatocarcinogenesis
  • 16. Experimental Models for Preclinical Research in Hepatocellular Carcinoma.